Pharmaceuticals
New Targets for Merck Stock as Charts Point Higher
Investors and traders should approach MRK from the long side.
Bulls Walk the Market Up Slowly, but Keep One Eye on Fed
I'm inclined to add to Disney on today's weakness.
Don't Jump Into Charles River Labs Just Yet
CRL could weaken further in upcoming weeks for a better buying opportunity.
IPO Gives Chinese Couple a 'Hansoh' Sum
The initial public offering of Hansoh Pharmaceutical Group made the Chinese couple Zhong Huijuan and Sun Piaoyang the richest in the nation.
Eli Lilly Broke Below the 200-Day Average to Change the Narrative to Bearish
Let's step back and look at the bigger picture through charts and indicators.
Thor Industries and Eli Lilly Offer a Tale of Two Stocks
The charts of the maker of recreational vehicles are bearish, while the drugmaker appears to be a buy
China's Drugmakers Under Scrutiny After Stanford Admissions Scandal
Chinese authorities are auditing the books of 77 drugmakers, including three multinationals, they say were selected at random. Were they motivated by embarrassment over a college-admissions payment made by a Chinese pharmaceuticals' tycoon?
Mirati Therapeutics Could Soar Even Higher
Prices went vertical early this month on heavy volume.
AMAG Pharmaceuticals Could Be Cut in Half Even From Here - Avoid
I was not familiar with the company nor the chart of the stock so it got my attention. Let's check.
Emergent BioSolutions Looks Like It Will Get a Shot in the Arm
EBS stock is poised to make a tradable rally in the weeks ahead.